Johnson & Johnson accepted nearly $2 billion from Cardinal Health for its pioneering stent business. The acquisition of Cordis is expected to close in late 2015.

Proponents of transcatheter aortic valve replacement (TAVR) have taken lessons from of others to orchestrate careful rollouts in Europe and the U.S. That cautious attitude could extend to other aspects of TAVR as well.

Patients undergoing cardiac surgery who received remote ischemic preconditioning had a significant reduction in the rate of acute kidney injury and the use of renal replacement therapy, according to a multicenter, double-blind, randomized trial in Germany.

A meta-analysis of 51 studies found that increases in body mass index were associated with a significant risk of atrial fibrillation (AF). The results were consistent across different clinical settings.

People with peripheral artery disease (PAD) who adhered to unsupervised, home-based walking exercise had improved functioning and mobility up to a year after beginning the regimen.

Thoratec Corporation, a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced that the FDA has granted conditional approval for a U.S. IDE clinical trial to investigate use of the HeartMate PHP acute catheter-based heart pump in patients undergoing a high-risk percutaneous coronary intervention.

A retrospective cohort study found that patients with venous thromboembolism who received bridge therapy had a 17-fold increase in the risk of bleeding during warfarin therapy interruption for invasive procedures compared with those who did not receive bridge therapy.

An analysis of TRANSLATE-ACS data supports current guideline recommendations to prescribe low-dose aspirin to patients who underwent PCI and received dual antiplatelet therapy. The study was published online May 20 in Circulation.